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Abstract
1. The rates of histamine release from the liver, skin and muscle by four kinds of histamine-
releasing substances, sinomenine, compound 48/80, tween 20 and polyvinylpyrrolidone (PVP),
were compared by intravenous injection in dogs, each in a dosage to cause a fall of approximately
80 per cent in the arterial blood pressure. 2. By compound 48/80, the rates were especially marked
from the liver and muscle and only slight from the skin, while those by sinomenine, tween 20 and
PVP were largest from the skin, followed by those from the liver and muscle, in that order. The
rate of histamine release from the skin by PVP was characteristic in that it was far larger than
that by other releasers. 3. On direct application of the drug solutions to the excised tissues of the
liver and skin the rates of release of histamine differed only slightly by the tissue in any of these
releasers 4. Some considerations were given on the reason for the different ratios by the organ of
in vivo histamine release though as yet no definite conclusion could be drawn.
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Since ALAM et al.]) discovered the action of curare in releasing hista-
mine from the skeletal muscle, numerous reports have been made on the
release of histamine from mammalian tissues by many organic chemical
substances including basic compounds, large molecules and surface-active
agents. These substances seem not to release histamine in the same ratio
from any of the tissues. It is known that curare liberates histamine from
the skeletal muscle in perfusion but not to a detectable amount from the
lung1). MACINTOSH and PATON2) reported that licheniformin as well as a
large number of related compounds with the structure of an organic base
liberate histamine from the skin and muscle of a cat but not from the
liver. According to HALPERN3\ in rats receiving several injections of
dextran and no longer capable of releasing histamine by this substance,
another releaser, compound 48/80, was still able to cause a typical ana-
phylactic response.
Formerly, it had been our belief that the chief source of histamine
liberated in dogs is the liver, for it is known that the liver is the richest
organ in histamine in this animal and that the large amount of histamine
is liberated from this organ during anaphylactic4,5) and peptone shock6).
A more recent study of MACINTOSH and PATON2) suggests that the same
thing may be said of the action of numerous other basic organic com-
pounds. However, MAYEDA7,8) in our laboratory, having found the his-
tamine-releasing activity of sinomenine, an alkaloid of Sinomenium acu-
tum Rehd., demonstrated that this liberates histamine in a much higher
rate from the skin rather than from the liver when injected intravenously
in this animal. These observations suggest that it would be interesting
to study the main sites of histamine release, yet to be known, of other
powerful histamine releasers.
In the present experiments, compound 48/80 (organic base)9), tween
1) Aided by a grant for Fundamental Scientific Research from the Ministry of
Education.
2) Preliminary note in Folia pharmacol. japon. 53, 74 § , 1957.
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20 (surface-active agent)10.11) and polyvinylpyrrolidone (large molecular
compound)12. 13. 14~ and also sinomenine were injected intravenously in dogs
and the rates of histamine release from the liver, skin and skeletal muscle
were quantitatively examined, and these results were compared with that
of the in vitro study of histamine release from the liver and the skin
tissues.
METHODS
Adult dogs weighing 7-12 kg. were anesthetized by an intravenous
injection of 40 mg./kg. of amytal sodium for the experiments. The relea·
sers, sinomenine hydrochloride3, compound 48/80 4 (condensation product
of p-methoxyphenethylmethylamine with formaldehyde), tween 20 and
polyvinylpyrrolidone5 (PVP, mol. wt., 25,000-35,000), were all injected
into the femoral vein respective dosage of 3, 0.7, 10 and 350 mg.jkg.,
which were determined to be necessary for causing about 80 per cent fall
of the arterial blood pressure. These substances were dissolved in 0.9%
saline solution to the concentration of 3, 0.1, 10 and 35 per cent, respec-
tively, and injected within 30 seconds, except PVP which was given
within 5 minutes.
Measurement of in vivo histamine release from the skin, muscle
and liver. Liver sample was removed from the terminal lobes, skin from
the outer sides of the femur and also from the ears in a part of experi-
ments, and muscle from m. glutaeus maximus, all in an amount necessary
to provide for a 3g. sample, from the left side prior to the injection of the
releasers and from the corresponding right side portion 30 minutes after
th.e injection. Of the skin pieces, hair and the subcutaneous tissues were
removed as much as possible. Cares were taken to arrest bleeding during
and also after resection of these tissues. The excised tissues were washed
with 0.9% saline solution, gross moisture was wiped off with a piece of
filter paper, and weighed. .
For extraction of histamine, 3 g. of finely cut tissues were boiled with
10 c. c. of N-hydrochloric acid for 10 minutes in a water bath, ground
with quartz sand, centrifuged, and the supernatant (extract) was sepa-
rated. In a part of experiments. the CODE method15) was adopted for same
3) Sinomenine hydrochloride was generously supplied by the Shionogi Research
Laboratories, Imafuku 192, Amagasaki.
4) Compound 48/80 was obtained through the kindness of Dr. EDWIN J. DE BEER,
the Wellcome Research Laboratories, Tuskahoe 7, New York.
5) Polyvinylpyrrolidone was obtained through the courtesy of the Ono Pharma-
ceutical Industries, Doshomachi 2, Osaka.
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purpose. The extract solutions were then neutralized with N-sodium
hydroxide and assayed for histamine with a piece of guinea pig ileum
suspended in a bath of Tyrode solution containing 0.05 fl.g';c. c. of atropine
sulfate. The fact that the effect of an active substance was suppressed by
neoantergan to the same degree as that of equiactive histamine served for
identification of histamine action. The amount of the other components
(including K+) in the extract effecting contraction in the presence of neo-
antergan, was quite small enough to be negligible for the present purpose
of histamine assay. For the calculation of the total amount of histamine
released from the whole organ, dimension of the skin of whole body was
roughly computed by the RUBNER methodt6). Total weight of the skeletal
muscle was calculated as 39 per cent of body weight; this percentage was
based on actual measurements of three dogs similar in stature to the ani-
mals used for the present experiment. In spite of the evidences pointing
differences in contents of histamine in various regions of the skin, the
value of femoral skin was used as a basis of calculation for the reason that
it is representative content in comparatively wide range of the skin17).
The weight of the liver was measured after removing as much blood as
possible.
Measurement of in vitro histamine release from excised tissues.
The skin, removed of hair and subcutaneous tissue, was stretched on a
cork board, pinned to the original size, and cut into st1"ips of 0.7 mm.
width with a mincer made by fixing several safety razor blades placed in
parallel with the same spacings. The liver was cut into flat pieces of
about 1.5 mm. in thickness with two parallel blades and again cut into
strips of 1.5 mm. width in the same manner as with the skin. Several
divisions of 100-200 mg. of minced tissues, obtained from the same
tissue, were used for each experiment. Flat-bottomed test tubes, each
containing 0.9% saline solution with test substance, tissue piece and a
glass bead of 3 mm. diameter for agitating this mixture, were shaken 100
rounds per minute for a distance of 5 cm. in a bath of 37°C for 60 minutes.
The quantity of histamine diffusing out in the medium was determined
with a piece of guinea pig ileum. In order to make accurate assay of his-
tamine, the amount of the releasers contained in the test solution was
added into the bath together with the standard histamine solution. The
rate of histamine release by each releasers was calculated by the following
equation:
Rate of histamine
release (%) = Total amt. released - spontaneous release x 100
Residual amt. in the tissue +total amt. released
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Measurement of arterial blood pressure. In experiments on in vivo
histamine release, the pressure of femoral artery was also recorded kymo-
graphically through a mercury manometer. The maximum rate of hypo-
tension was indicated in the records for 30 minutes after the injection.
RESULTS
Immediately after the injection of sinomenine or compound 48/80,
arterial blood pressure showed a sudden fall after a slight rise for 20-30
seconds, reached the minimum in 1-2 minutes where it stayed for some
time, then gradually tended to recovery. The maximum fall of blood
pressure during 30 minutes after the injection was about the same degree
in the two releasers in the present doses, i. e. 83 (80-87) per cent by
sinomenine and 83 (78-85) per cent by compound 48/80. The delayed
depressor effect, a characteristic of histamine-releasing actio1l2) was ob-
served by these relcasers. The latent period until the fall of blood pressure
seemed to be slightly shorter in compound 48/80 than in sinomenine.
With the injection of tween 20 and PVP, there was 110 transitory rise of
blood pressure. It began to fall by the end of injection of tween 20. How~
Table 1. The rate of histamine release by sinomenine from the liver,
skin and muscle in dogs, with maximal fall of blood pressure.
Exp, dog I Organ
I
B f
I
Aft I D'ff ! 96 h' t I Hist. released I Max. fall of; ore . er 1 e- is . . from the I B. P. within
Smom. Smom. I rence release I whole organ 30 min.
Liver
Skin
Muscle
I
9.0 kg. ~
! (/Lg.jg.) (/ig.jg.) (/ig.jg.) I (mg.) (%)
44.2 34.0 10.2 I 23.0 3.4
12.2 8.8 3.4 27.8 1. 8 87
2.2 I 2.2 0 0 0
I------..:,.......--+---~ I Total 5.2
]I
7.0kg. ~
Liver 61.2
Skin 10.9
Muscle 2.0
47.6
8.2
2.0
13.6 22.2 4.0
2.7 25.0 1.2
000
Total 5.2
80
][
7.0kg. 0
Liver 68.0
Skin 12.1
Muscle 2.1
61.2
8.1
1.9
6.8 10.0 1.9
4.0 33.3 1.7
0.16 7.8 0.44
Total 4.0
82
Average
Liver
Skin
Muscle
57.8
11. 8
2.1
47.6
8.4
2.0
I 10.2
1
1
3.1
0.05
I
I
18.4
28.7
3.6
3.1
1.6
0.15
Total 4.9
83
4
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ever, this initial fall was slight and either it stopped or showed a slight
temporary rise before going to a profound fall, reaching the maximum of
81 (79-85) per cent fall in 2-4 minutes after the end of injection. The
earlier onset of the fall of blood pressure by tween 20 may not be due to
liberated histamine but probably due to the action of this substance itself.
With PVP, a more gradual fall than the foregoing three substances began
1-3 minutes after beginning of the injection, the blood pressure reaching
the minimum after 4-5 minutes, and returned to normal in a compara-
tively short time. The rate of maximum fall of blood pressure was rather
smaller than that of the others, being 73 (69-79) per cent. This compara-
,tively mild fall of blood pressure may have some bearing on the slow
Table 2. The rate of histamine release of compound 48/80 from the liver,
skin and muscle in dogs, with maximal fall of blood pressure.
I
Belo," IAf'« IDiffe·1 % hi"·1 Hi". rel:"ed Max. fall ofExp. dog Organ 48/80 48/80 rence release w~~~~or~ean B. P. within30 min.
I Liver
(/Lg-!g.) (/Lg./g.) (/Lg./g.)
I
(mg.) (%)
40.8 25.8 15.0 36.7 5.5
I 6.1 6.1 0.68 11.1 0.4 83Skin
11.0 kg. ~ (27.2) (24.5) (2.7) (l0.0)
Muscle 2.2 1.7 0.56 25.0 2.4
I Total 8.3
I
i Liver 68.0 46 .. 2 2l.B I 32.0 I 7.7
II I Skin 8.8 8.2 0.68 I 7.7 0.25 85
I
(40.8) (29.9) (10.9) I (26.7) ,
10.0 kg. 8 i Muscle 2.0 1.1 0.84 I 42.9 I 3.3
! Total 11.3
, 1
I Liver 34.0 I 20.4 ! 13.6 40.0 4.7lIT*
I Skin 6.1
:
4.8 1.4 22.2 0.79 78
10.5 kg. ~ i Muscle 1.4 1.0 0.42 30.0 1.7 iI Total 7.2I
I Liver 54.4 37.4 I 17.0
I
31.3 4.9 IiIV*
1 Skin 6.8 5.8
I
1.0 15.0 0.51 85i
9.0kg. ~ IMu,"le 1.7 1.1 0.56 I 33.3 2.0 i
I
I
[ Total 7.4 II
Liver
I
49.3 32.5 16.8 35.0 5.7
Skin 7.0 6.6 0.94 14.1 0.49 83
Average I (34.0) (27.2) (6.8) (18.3)
Muscle I 1.8 1.2 0.60 32.8 2.3
I Total 8.5
I
Values in parentheses refer to histamine content of the aural skin.
* CODE's method for histamine extraction.
5
Nishiyama et al.: The Sites of Action of some Histamin-Releasing Substances in the
Produced by The Berkeley Electronic Press, 1957
138 R. NISHIYAMA, K. T ASAKA and S. IRINO
speed of injection.
Results on histamine release from the liver, skin and skeletal muscle
by the intravenous injection of these four substances are shown in Tables
1-4.
Of the data for the skin, the values in parentheses are those obtained
with the skin of the ear lobe, which contains high amount of histamine.
The histamine contents in the liver, skin and muscle of normal dogs had
been ascertained as being approximately the same at corresponding posi·
tions on the left and right sides by preliminary experiment with two dogs.
Table 3. The rate of histamine release by tween 20 from the liver. skin
and muscle in dogs, with maximal fall of blood pressure.
Exp. dog I I. Before I After IDiffe- i. % hist.!. Hist. released IMax. f~ll .of
I
Organ Tween Tween I I I from the B. P. wIthIn
20 20 rence i re ease I whole organ 30 min.
I '
I
8.0 kg.
i (/lg./g.)
Liver !I 44.8
Skin I 12.9
o I (36.4)
I Mu'cle I 28
(/lg./g.) I (/lg./g.) i
36.4 I 8.4 I
8.2 i 4.8 I
(14.6)1 (21.8) .
2.5 I 0.28 i
I I!
i I
I (mg.)
18.8 I 2.8
36.81 2.1(59.9)
10.0 I 0.87
I TotalS. 8
(%)
80
81
79
85
3.5
2.4
2.6
2.7
0.66
Total 6.0
I
0.98
Total 6.9
14.3
60.3
10.0
6.8
4.1
0.14
8.4 I
1
17.7
4.8 44.1
(18.8) I (49.0)
0.281 5.6
40.8 I
2.7 i
1.3 J
38.8
5.7
(17.1)
2.6
1
1 39.2 I
6.1
(19.6)
I 48
46.7
10.2
(37.4)
3.1
47.6
10.9
(38.4)
5.0
I 47.6
6.8
1.4
Muscle
Liver
Skin
Muscle
Liver
Skin
I~~::'
I Muscle
Average
IT
9.0 kg. ~
m*
12.0 kg. ~
7.9 I 16.9 I 3.0 1
14.5 47.1 2.4
(20.3) ! (54.4),.
0.23 1[ 8.5 0.84 I
I Total 6.2'-----=-::---~~~i--L------lI_
Values in parentheses refer to histamine content of the aural skin.
* CODE's method for histamine extraction.
The percentage rate of release of histamine by sinomenine was largest
in the skin among the three organs but the total amount of histamine
released from each whole organ was largest in the liver, followed by the
skin and muscle in that order. Histamine release from the muscle was
smallest in the present experiment, differing from the report of MAYEDA8).
6
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Table 4. The rate of histamine release by PVP from the liver, skin and
muscle in dogs, with maximal fall of blood pressure.
139
Exp. dog Organ IBefore IAfter IDiHe·1 % hi".] Hi". relea..dIMax. bll.ofPVP PVP rence release from the B. P. w~thm
whole organ 30 mm.
(f.Lg.jg.) l (f.Lg.jg.) (f.Lg.jg.) (mg.) (%)
I Liver 67.4 60.6 6.8 10.1 2.2
Skin 13.5 7.4 6.1 45.0 3.6 69
9.9 kg. 0 Muscle 1.7
I
1.5 0.14 8.3 0.54
I
Total 6.3 I
I
I
I Liver 74.8 68.0 6.8 9.1 2.3II Skin 10.9 5.4 5.4 50.0 3.2 69
10.0 kg. 0 I Mu,cle 1.8 1.8 0.07 3.8 0.27
Total 5.8
Liver 30.8 25.2 5.6 18.2 1.9
lli* Skin 9.4 4.7 4.7 49.9 2.6 82
10.0 kg. 0 Muscle 1.5 1.5 0.08 5.2 0.31
Total 4.8
Liver 57.7 51.3 6.4 12.5 2.2
Average Skin 11.3 5.9 5.4 48.3 3.1 73
Muscle 1.7 1.6 0.10 5.8 0.37
Total 5.7
* CODE's method for histamine extraction.
In the case of compound 48/80, the rate of release of histamine was
marked from both the liver and muscle, that from the skin being slight.
With the organ as a whole, the amount released was overwhelmingly large
from the liver. Total amount of histamine released from the three organs
was larger than that in the case of sinomenine.
The percentage rate of release of histamine by tween 20 was larger
from the skin than from the other organs and the amount released from
the skin was far larger than that by sinomenine. The rate of release was
larger from the aural skin than from that of the thigh. The latter result
agrees with KUME'S finding17) with sinomenine in the dog.
The effect of PVP was similar to that of tween 20 but only difference
was that with PVP the release from the skin is by far greater than that
from the liver or muscle as compared with the case of the latter releaser.
The total amount of histamine released from these three organs by PVP
was rather smaller than that by the other substances.
Table 5 shows the rate of in vitro histamine release from the liver
and skin by these four kinds of substances, measured by the method
7
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Table 5. The rate of in vitro histamine release by some releasers
from minced tissues of the dog's liver and skin.
I T;sJ Histamine release (%)No. Iof Sinomenine HCI Compound 48/80 Tween 20 PVPexpo
I I I I0.2% 1.0% 0.02% 0.1% 0.5% 3.0% 3.5%I
10.4 15.0 I 9.4 16.6 I 23.8 I 29.0 27.1
Liver 5 (8.1-12.5) (12.8-16.1)I(8.1-10.8) (15.3 -17.5) (14.8 -27.0) i (17.6 -32.4) (14.3-31.5)
13.2 28.718.3 I 7.8 I 11.1 24.1 30.7
Skin 5 I (9.6-15.1) (13.5-20.2)1 (6.3-9.1) (7.3-14.6) 1C15.2-27.5Y16.9-34.8) (14.6-33.1)
Table 6. Histamine contents and percentages of spontaneous
histamine release of the tissues used in the
experiments in Table 5.
I
I
Histamine content
I
Spontaneous histamine
I
Tissue (pg./g. tissue) release (%)
I
•
45.2 3.4
Liver (25.1-70.3) (2.2-4.1)
11. 7 7.1
Skin (6.4-17.3) (4.1-10.2)
-
described above. Histamine contents and the spontaneous release of these
tissues are shown in Table 6. The concentration of releasers, with the
exception of PVP, was selected by the ratio of dosages causing about the
same degree of hypotension. The action of these substances was examined
with the two organs of each dog at the same time. All the values listed
are obtained with five dogs. The ratio of release differs with each sub-
stance but there is no marked difference from the liver and skin by any
of these substances. This could not have been anticipated in the result of
the in vivo experiment.
DISCUSSION
The results of the present experiments have indicated that the rates
of release of histamine from different organs are not necessarily the same
by any histamine-releasing substance given intravenously. The rate of
release by sinomenine was found to be greatest from the skin, followed
by that from the liver, as was reported by MAYEDA8), but the total amount
released from each organ was greater from the liver, differing from his
result. This may be due to the fact that in the present experiment weight
8
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of the liver of the dogs was greater than that used by MAYEDA8), probably
owing to the difference in nutrition, as may be imagined from the weight
ratio of the whole muscles.
Release of histamine by compound 48/80 was largest from the liver
and smallest from the skin, and this was approximately the same as the
results obtained by MAYEDA8) with peptone. NISHIYAMA18) indicated that
the release of histamine from the liver was greater than that from the
skin during anaphylactic shock in dogs. Both tween 20 and PVP effected
a greater release of histamine from the skin than from other two organs,
and this difference was especially marked in PVP.
The question as to what caused the difference in the degree of hista-
mine release from these organs by these substances cannot be answered
fully with our present knowledge on the mode of binding of histamine in
the cells and on the mechanism of its release. There is no similarity in
the chemical structure of compound 48/80 and of sinomenine but they
may be of the same category in that they are both basic compounds.
Although there is a difference that sinomenine releases a larger amount
of skin histamine than compound 48/80, these two substances are powerful
releasers of liver histamine. This seems to be also true with licheniformin,
and also other diamines, diamidines, diguanidines, bis-quaternary bases,
as well as benzamidine derivatives2), MONGAR and SCHILD19) called atten-
tion, in their studies on in vitro histamine release from various organs of
guinea pigs, to some similarity of compound 48/80 or D-tubocurarine and
anaphylaxis in their action. KAMIMURA20) observed that the action of sino-
menine was also similar to these compounds on this point. It has been
suggested by ELDRIDGE and PATON21 ) that the histamine-releasing action
of peptone is at least partly due to basic amino acids, arginine and lysine
contained in it. Would it not be possible, then, to explain such common
characteristics of action of these substances by the hypothesis that these
substances replace histamine by binding with acidic residues in the tissue?
Compound 48/80 abundantly releases histamine from mast cells but
does not seem to release histamine from other tissues22 ). Dog liver is
especially rich in mast cells, which are found around the fine blood vessels
and in the wall of sinusoids23), easily accessible by the circulating chemical
substances. It follows, therefore, that a series of histamine-releasing
substances having strong affinity to these cells can readily liberate hista-
mine from the liver. YAMASAKI and KAWAMOT024) have observed that
intravenously injected peptone disrupts only a few mast cells of the skin
but tween 20 and PVP effect strong change of these cells in the skin rather
than in the liver, in proportion to the intensity of their histamine releasing
9
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action iu our present study. Therefore, difference in the site of histamine
release can not be explained only by the affinity of certain substances to
mast cells.
The most simple explanation may be the one based on the hypothesis
that such difference is produced by a variety in local concentration of the
chemicals distributed after injection but yet there is no experimental
evidence to support such a belief. MAcINTosH25) tried to explain the dif-
ferences of in vitro and in vivo effects of some basic compounds in con-
nection with their binding power with hematocytes, plasma proteins, or
heparin in vivo. According to the hypothesis that the activity of an
enzyme is involved in the action of histamine-releasing substances26• Z7),
differences in the tissue element taking part in protease activation may
give different effects on histamine releasing effect of such substances, but
it is impossible to detemine at present whether or not protease activation
has any causal relation to the histamine release.
In contrast with such non-uniformity of histamine release from tissues
in vivo, the in vitro experiment showed no marked difference in the rates
of release of histamine from the liver and skin pieces by any of these sub-
stances. This suggests that there are some differences in the mechanism
of histamine release under these two kinds of experimental conditions. In
one, the releasers reach the tissue via the blood, while in the other, they
penetrate into the tissue cells directly from their surface. The fact that
histamine is not released from the lung of a guinea pig by intravenous
injection or perfusion of compound 48/8()28. 29) or sinomenine30) but a large
amount of it is released on direct application of the drug solutions on the
excised tissue pieces of this animal20• 31) may also be explained similarly. A
similar ratio of the in vitro liberation of histamine from different tissues
(such as the skin and liver) may be due to the fact that the action of re-
leasers is manifested chiefly through its action on the surface membrane
of histamine-containing cells, as PATON32) has suggested.
. ; The difference in the site of action of histamine-releasing substances
in vivo seems to be fundamentally related to the mechanism of histamine
release, as is also true with differences in effects according to the differ-
ences in species of animals; therefore more extensive studies are desired
for clarifying the reason for these phenomena.
SUMMARY
1. The rates of histamine release from the liver, skin and muscle by
four kinds of histamine-releasing substances, sinomenine, compound
48/80, tween 20 and polyvinylpyrrolidone (PVP), were compared by in-
10
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travenous injection in dogs, each in a dosage to cause a fall of approxi-
mately 80 per cent in the arterial blood pressure.
2. By compound 48/80, the rates were especially marked from the
liver and muscle and only slight from the skin, while those by sinomenine,
tween 20 and PVP were largest from the skin, followed by those from the
liver and muscle, in that order. The rate of histamine release from the
skin by PVP was characteristic in that it was far la:rger than that by other
releasers.
3. On direct application of the drug solutions to the excised tissues
of the liver and skin the rates of release of histamine differed only slightly
by the tissue in any of these releasers
4. Some considerations were given on the reason for the different
ratios by the organ of in vivo histamine release though as yet no definite
conclusion could be drawn.
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